Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
Dapavo P, Siliquini N, Mastorino L, Avallone G, Merli M, Agostini A, Cariti C, Viola R, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Ribero S. Dapavo P, et al. Among authors: siliquini n. J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13. J Dermatolog Treat. 2022. PMID: 34315331 Free article.
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: siliquini n. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
Combination of dermabrasion and Apremilast for Hailey-Hailey disease.
Siliquini N, Deboli T, Marchetti Cautela J, Mangia A, Fraccalvieri M, Dapavo P, Quaglino P, Ribero S. Siliquini N, et al. Ital J Dermatol Venerol. 2021 Dec;156(6):727-728. doi: 10.23736/S2784-8671.20.06540-2. Epub 2020 Mar 4. Ital J Dermatol Venerol. 2021. PMID: 32129590 No abstract available.
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting.
Ribero S, Ramondetta A, Fabbrocini G, Bettoli V, Potenza C, Chiricozzi A, Licciardello M, Marzano AV, Bianchi L, Rozzo G, Fania L, Marasca C, Odorici G, Mambrin A, Moltrasio C, Caposiena Caro RD, Skroza N, Quaglino P, Siliquini N, Dapavo P. Ribero S, et al. Among authors: siliquini n. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e441-e442. doi: 10.1111/jdv.17178. Epub 2021 Mar 9. J Eur Acad Dermatol Venereol. 2021. PMID: 33594790 No abstract available.
Atopic dermatitis, dupilumab and cancers: a case series.
Siliquini N, Giura MT, Viola R, Ribero S, Panzone M, Dapavo P, Fierro MT, Ortoncelli M, Quaglino P. Siliquini N, et al. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e651-e652. doi: 10.1111/jdv.17264. Epub 2021 Jun 11. J Eur Acad Dermatol Venereol. 2021. PMID: 33797094 No abstract available.
Misuse, consequences and phototoxic skin-related effects of Rutaceae.
Avallone G, Mastorino L, Agostini A, Merli M, Siliquini N, Rubatto M, Fierro MT, Ribero S, Quaglino P. Avallone G, et al. Among authors: siliquini n. Ital J Dermatol Venerol. 2022 Apr;157(2):126-131. doi: 10.23736/S2784-8671.21.06944-9. Epub 2021 Apr 29. Ital J Dermatol Venerol. 2022. PMID: 33913673
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Gallo G, Rostagno E, Siliquini N, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Dapavo P, Ribero S. Gallo G, et al. Among authors: siliquini n. Australas J Dermatol. 2021 Aug;62(3):e431-e432. doi: 10.1111/ajd.13632. Epub 2021 May 27. Australas J Dermatol. 2021. PMID: 34042171 No abstract available.
29 results